Stay up to date with the latest developments in urinary biomarkers for bladder cancer and UTUC. Explore educational articles, scientific reviews, expert commentaries, and clinical cases covering emerging evidence and evolving approaches to detection and surveillance.
Henry, a 70-year-old former creative director in a chocolate company, was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He received 1 immediate chemotherapy instillation during...
Key perspectives from the EAU guidelines panelReviewed by Paolo Gontero The current standard-of-care for NMIBC surveillance The 2025 EAU guidelines recommend cystoscopy as standard-of-care...
Reviewed by Marek Babjuk and Paolo Gontero The 2024 EAU guidelines mention a study concluding that FISH and Bladder EpiCheck® along with cytology could be helpful as an ancillary tool in the...
Improvements in the initial diagnostic workup for bladder cancer Did you know that you can decrease your patient's burden and discomfort during the initial workup for bladder cancer with the...
Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the...
Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial...